Global Multiplexed Diagnostics Market US$ 12.5 Billion by 2021

Global Multiplexed Diagnostics Market US$ 12.5 Billion by 2021

According to a market research report Multiplexed Diagnostics Market 2017-2021 published by iHealthcareAnalyst, Inc., the global multiplexed diagnostics market is estimated to reach US$ 10.7 Billion in 2020, expanding at a CAGR of 17.4% from 2017 to 2021.

Visit the Multiplexed Diagnostics Market 2017-2021 report at

The global multiplexed diagnostics market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global multiplexed diagnostics market segmentation is based on technology (low density multiplexed assays, microplate assays, quantitative PCR, medium density multiplexed assays, antibody arrays, bead-based arrays, mass spectrometry, reverse arrays, high density multiplexed assays, bacterial artificial chromosome arrays, protein arrays, very high density multiplexed assays, oligonucleotide arrays, phage display, next generation sequencing assays), and applications (allergies, autoimmune diseases, cardiac disorders, infectious disease diagnosis, oncology).

The global multiplexed diagnostics market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global multiplexed diagnostics market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

  1. Technology
    • Low Density Multiplexed Assays (plex ≤ 5)
      • Microplate Assays
      • Quantitative PCR
    • Medium Density Multiplexed Assays (plex < 500)
      • Antibody Arrays
      • Bead-based Arrays
      • Mass Spectrometry
      • Reverse Arrays
    • High Density Multiplexed Assays (500 ≤ plex ≤ 10,000)
      • Bacterial Artificial Chromosome Arrays
      • Protein Arrays
    • Very High Density Multiplexed Assays (> 10,000-plex)
      • Oligonucleotide Arrays
      • Phage Display
    • Next Generation Sequencing Assays
  1. Application
    • Allergies
    • Autoimmune diseases
    • Cardiac Disorders
    • Infectious Disease Diagnosis
    • Oncology
    • Others
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Affymetrix, Inc.
    • Agilent Technologies, Inc.
    • bioMerieux, Inc.
    • Bio-Rad Laboratories, Inc.
    • Illumina, Inc.
    • Hoffman-La Roche, Ltd.
    • Gen-Probe, Inc.
    • Life Technologies Corporation
    • Luminex Corporation
    • Seegene, Inc.

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]

2017-11-05T09:59:34+00:00 Categories: Press Releases|